EntrepreneurialCheck
Albert Huang estimated net worth profile

Albert Huang net worth

Albert Huang Net Worth 2026 (Estimated) · CEO at Allotrope Medical · YC S18
est. wealth $15.0M

Quick answer

Albert Huang's estimated net worth is $15.0M (range $10.5M – $22.5M) as of 2026. Albert Huang is CEO at Allotrope Medical. Allotrope Medical valuation.

Albert Huang is CEO at Allotrope Medical (YC S18). Independent Entrepreneurial Check model estimate from public YC data.

At a glance

NameAlbert Huang
RoleCEO
CompanyAllotrope Medical
YC batchS18
Est. company val$100.0M
Assumed ownership15%
Est. paper wealth / net worth$15.0M
$10.5M – $22.5M
  • Company status: Acquired
  • Education: Stanford University
  • Region: United States of America
  • Industries: Healthcare, Medical Devices
  • Team size: 2
  • Website: http://www.allotropemed.com

Who is Albert Huang?

Albert Huang is a founder at Allotrope Medical, a Y Combinator company from the Summer 2018 batch.

Highlights:

  • Stanford University
  • Harvard University
  • Worked at Medtronic

About Allotrope Medical

Allotrope Medical is a Houston-based medical device company founded and run by the surgeon that created the technology.

Our platform stimulation technology gives physicians control over the natural movements of the urinary and digestive systems. This control over smooth muscle tissues allows the surgeon to identify hidden anatomic structures (ureters, sphincters and others), determine tissue health, and even...

FAQ: Albert Huang net worth and Allotrope Medical valuation

What is Albert Huang's net worth?

Albert Huang's estimated net worth is $15.0M (range $10.5M – $22.5M) as of 2026. Albert Huang is CEO at Allotrope Medical. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.

What is Allotrope Medical valuation?

Allotrope Medical's estimated valuation on Entrepreneurial Check is $100.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.

What is Albert Huang's role?

Albert Huang is CEO at Allotrope Medical, a Y Combinator-backed startup (batch S18).